Efficacy and Safety of Extended Release and Immediate Release Febuxostat in Participants With Gout

NCT02139046 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1790

Enrollment

INDUSTRY

Sponsor class

Conditions

Gout

Interventions

DRUG: Febuxostat IR
DRUG: Febuxostat XR
DRUG: Febuxostat placebo
DRUG: Colchicine
DRUG: Naproxen
DRUG: Lansoprazole

Sponsor

Takeda